PLRX Pliant Therapeutics, Inc.
Healthcare$1.24+2.48%ClosedMarket Cap: $76.8M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.45
P/S
0.00
EV/EBITDA
-0.74
DCF Value
$0.27
FCF Yield
-131.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-59.1%
ROA
-55.9%
ROIC
-61.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-21.8M | $-20.0M | $— | — |
| Q4 null | $0.00 | NaN% | $-23.6M | $-23.6M | $— | — |
| FY null | $0.00 | -Infinity% | $-150.1M | $-149.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-28.3M | $-26.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-45.6M | $-43.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-58.9M | $-56.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-53.3M | $-49.7M | $— | — |
| FY null | $0.00 | NaN% | $-228.4M | $-210.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-62.0M | $-57.8M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-60.6M | $-55.9M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-52.4M | $-47.0M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-47.0M | $-41.1M | $-0.69 | — |